$QSJC
Tancheng Group Co Ltd

2024 Q4 Form 10-Q Financial Statement

#000168316824008012 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $145.8K $626.0K
YoY Change -76.71%
Cost Of Revenue $105.1K $458.4K
YoY Change -77.07% 242.34%
Gross Profit $40.64K $167.6K
YoY Change -75.75% 770.78%
Gross Profit Margin 27.88% 26.77%
Selling, General & Admin $94.65K $145.0K
YoY Change -34.71% 874.9%
% of Gross Profit 232.9% 86.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.713K $6.781K
YoY Change -1.0% 653.44%
% of Gross Profit 16.52% 4.05%
Operating Expenses $94.65K $145.0K
YoY Change -34.71% 819.26%
Operating Profit -$54.01K $22.62K
YoY Change -338.75% -165.17%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$53.94K $23.03K
YoY Change -334.21% -246.04%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$53.94K $23.03K
YoY Change -334.21% -246.04%
Net Earnings / Revenue -37.01% 3.68%
Basic Earnings Per Share -$0.01 $0.01
Diluted Earnings Per Share -$0.01 $0.01
COMMON SHARES
Basic Shares Outstanding 4.382M shares 4.382M shares 4.382M shares
Diluted Shares Outstanding 4.382M shares 4.382M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $189.8K $463.0K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $1.297M $1.195M
Prepaid Expenses
Receivables
Other Receivables $927.00 $711.00
Total Short-Term Assets $1.531M $3.348M
YoY Change -54.28% 129563.67%
LONG-TERM ASSETS
Property, Plant & Equipment $105.4K $128.1K
YoY Change -17.72%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $105.4K $128.1K
YoY Change -17.72% 507.68%
TOTAL ASSETS
Total Short-Term Assets $1.531M $3.348M
Total Long-Term Assets $105.4K $128.1K
Total Assets $1.636M $3.476M
YoY Change -52.94% 14587.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $144.0K $152.4K
YoY Change -5.47% 2443.89%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.099M $4.586M
YoY Change -32.41% 3038.31%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.099M $4.586M
Total Long-Term Liabilities
Total Liabilities $3.099M $4.586M
YoY Change -32.41% 3038.31%
SHAREHOLDERS EQUITY
Retained Earnings -$1.668M -$1.349M
YoY Change 23.65% -1039.62%
Common Stock $4.382K $4.382K
YoY Change 0.0% 0.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.463M -$1.109M
YoY Change
Total Liabilities & Shareholders Equity $1.636M $3.476M
YoY Change -52.94% 14587.9%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$53.94K $23.03K
YoY Change -334.21% -246.04%
Depreciation, Depletion And Amortization $6.713K $6.781K
YoY Change -1.0% 653.44%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Address Address Line2
EntityAddressAddressLine2
Lvliang City
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Revenues
Revenues
302899 usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001753391
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Entity Address City Or Town
EntityAddressCityOrTown
Shanxi Province
dei Entity Address Country
EntityAddressCountry
CN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
030500
dei Country Region
CountryRegion
86
dei City Area Code
CityAreaCode
139
dei Local Phone Number
LocalPhoneNumber
1097-2765
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4381550 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
189842 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
412154 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1252150 usd
CY2024Q3 QSJC Advance To Suppliers
AdvanceToSuppliers
42356 usd
CY2023Q4 QSJC Advance To Suppliers
AdvanceToSuppliers
16200 usd
CY2024Q3 QSJC Amounts Due From Related Parties Current
AmountsDueFromRelatedPartiesCurrent
0 usd
CY2023Q4 QSJC Amounts Due From Related Parties Current
AmountsDueFromRelatedPartiesCurrent
1695750 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1530501 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
3376985 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
105416 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
124568 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
105416 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
124568 usd
CY2024Q3 us-gaap Assets
Assets
1635917 usd
CY2023Q4 us-gaap Assets
Assets
3501553 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
144038 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
153572 usd
CY2024Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
12230 usd
CY2024Q3 QSJC Amounts Due To Related Parties Current
AmountsDueToRelatedPartiesCurrent
2942868 usd
CY2023Q4 QSJC Amounts Due To Related Parties Current
AmountsDueToRelatedPartiesCurrent
4387838 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3099278 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4696852 usd
CY2024Q3 us-gaap Liabilities
Liabilities
3099278 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
4382 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
162864 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
162864 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
37515 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
50681 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1668122 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1413226 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1463361 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1195299 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1635917 usd
CY2024Q3 us-gaap Revenues
Revenues
145764 usd
CY2023Q3 us-gaap Revenues
Revenues
625954 usd
us-gaap Cost Of Revenue
CostOfRevenue
222642 usd
us-gaap Cost Of Revenue
CostOfRevenue
1506068 usd
us-gaap Gross Profit
GrossProfit
80257 usd
us-gaap Gross Profit
GrossProfit
320602 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6932 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20681 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20960 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
87558 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
138035 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
314651 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
526075 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
94653 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
144967 usd
us-gaap Operating Expenses
OperatingExpenses
335332 usd
us-gaap Operating Expenses
OperatingExpenses
547035 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-54012 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
22623 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-255075 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-226433 usd
CY2024Q3 us-gaap Other Income
OtherIncome
71 usd
CY2023Q3 us-gaap Other Income
OtherIncome
408 usd
us-gaap Other Income
OtherIncome
179 usd
us-gaap Other Income
OtherIncome
903 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-53941 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23031 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-254896 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-225530 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-53941 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
23031 usd
us-gaap Net Income Loss
NetIncomeLoss
-225530 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-35377 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-214 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-13166 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
45975 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-89318 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22817 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-268062 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-179555 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4381550 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4381550 shares
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-1109464 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1195299 usd
us-gaap Net Income Loss
NetIncomeLoss
-254896 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13166 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-1463361 usd
us-gaap Net Income Loss
NetIncomeLoss
-254896 usd
us-gaap Net Income Loss
NetIncomeLoss
-225530 usd
us-gaap Depreciation
Depreciation
20057 usd
us-gaap Depreciation
Depreciation
11412 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
186 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
268 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
30378 usd
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
43733 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-443053 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-539198 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-144146 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
221592 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1092970 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
391807 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
412154 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71207 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
189842 usd
us-gaap Net Income Loss
NetIncomeLoss
-254896 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-443053 usd
CY2024Q3 QSJC Working Capital
WorkingCapital
-1568777 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1668122 usd
us-gaap Depreciation
Depreciation
20057 usd
us-gaap Depreciation
Depreciation
11412 usd
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4381550 shares
CY2024Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Entity File Number
EntityFileNumber
000-56590
dei Entity Registrant Name
EntityRegistrantName
TANCHENG GROUP CO., LTD.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-4086827
dei Entity Address Address Line1
EntityAddressAddressLine1
No. 32, Huili Township, Jiaocheng County
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
927 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
731 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
1297376 usd
CY2023Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
12553 usd
CY2024Q3 QSJC Customers Advances Current
CustomersAdvancesCurrent
142 usd
CY2023Q4 QSJC Customers Advances Current
CustomersAdvancesCurrent
142889 usd
CY2023Q4 us-gaap Liabilities
Liabilities
4696852 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4381550 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4381550 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4381550 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4381550 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
4382 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3501553 usd
us-gaap Revenues
Revenues
1826670 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
105123 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
458364 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
40641 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
167590 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7095 usd
us-gaap Net Income Loss
NetIncomeLoss
-254896 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.012
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.012
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.005
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.005
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.058
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.058
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.051
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.051
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4381550 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4381550 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4381550 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4381550 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4381550 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4381550 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-929909 usd
us-gaap Net Income Loss
NetIncomeLoss
-225530 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
45975 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
577555 usd
us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
25345 usd
us-gaap Increase Decrease In Prepaid Supplies
IncreaseDecreaseInPrepaidSupplies
13934 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-10990 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
157864 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-453 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-22599 usd
QSJC Increase Decrease Customer Advances
IncreaseDecreaseCustomerAdvances
-140862 usd
QSJC Increase Decrease Customer Advances
IncreaseDecreaseCustomerAdvances
175145 usd
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-0 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
-0 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
144146 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
221592 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1092970 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-851 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-17819 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-222312 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
463014 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_zZ3I9d8yZOr4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(c) <span id="xdx_862_zRDoqHwFrk9i">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, related disclosures of contingent liabilities at the balance sheet date, and revenue and expenses in the financial statements and accompanying notes. Significant accounting estimates reflected in the Company’s condensed consolidated financial statements include economic lives and impairment of property, plant and equipment and allowance for doubtful accounts. Actual results could differ from those estimates and such differences could affect the results of operations reported in future periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zYLtnpaQ0dFk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(m) <span id="xdx_863_zqT04QUGgYx4">Concentration of Credit Risk</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially expose the Company to a significant concentration of credit risk consist primarily of cash and cash equivalents and other receivables. As of September 30, 2024 and December 31, 2023, substantially all of the Company’s cash and cash equivalents were deposited with financial institutions with high-credit ratings and quality. During the three and nine months ended September 30, 2024 and 2023, all revenues were generated from third parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Details of customer who accounted for 10% or more of the Company’s total revenue for the three and nine months ended September 30, 2024 and 2023 are as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zTKhQSocotmk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Customer concentation)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BB_z6t1ql1SC3ua" style="display: none">Schedule of concentration risk total revenue</span></td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td><td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="15" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the three months ended September 30,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of total revenue</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of total revenue</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%; text-align: justify">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20240701__20240930__srt--MajorCustomersAxis__custom--CustomerAMember_zCw1RcvvOzE5" style="width: 11%; text-align: right" title="Revenue">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span style="font-size: 10pt"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp0_c20240701__20240930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zjZ5HRX92Crh" title="Percentage of total revenue">–</span>%</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230701__20230930__srt--MajorCustomersAxis__custom--CustomerAMember_zJycbMhAWXu4" style="width: 11%; text-align: right" title="Revenue">100,408</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20230930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_z20gIJz66rf" title="Percentage of total revenue">16</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20240701__20240930__srt--MajorCustomersAxis__custom--CustomerBMember_zYxeYTlK6pc7" style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp0_c20240701__20240930__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zHuqsXB6Qjv5" title="Percentage of total revenue">–</span>%</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230701__20230930__srt--MajorCustomersAxis__custom--CustomerBMember_zSlvkS0yW4I" style="text-align: right">84,400</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp0_c20230701__20230930__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zQW0skCwHigl" title="Percentage of total revenue">14</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Customer C</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20240701__20240930__srt--MajorCustomersAxis__custom--CustomerCMember_z7wOz4Nfiw25" style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp0_c20240701__20240930__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zCFXH4rN65Qd" title="Percentage of total revenue">–</span>%</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230701__20230930__srt--MajorCustomersAxis__custom--CustomerCMember_zR4wOf8DUGph" style="text-align: right">63,606</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp0_c20230701__20230930__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_z0S8lGtCUyel" title="Percentage of total revenue">10</span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Customer D</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20240701__20240930__srt--MajorCustomersAxis__custom--CustomerDMember_zPVKWrceUM28" style="border-bottom: Black 1pt solid; text-align: right">144,700</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20240930__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zOboxqNoIU2d" title="Percentage of total revenue">99</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20230701__20230930__srt--MajorCustomersAxis__custom--CustomerDMember_z9k4QV8urXs" style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp0_c20230701__20230930__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zRcRNgqSHDsb" title="Percentage of total revenue">–</span>%</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240701__20240930__srt--MajorCustomersAxis__custom--TotalCustomerMember_z3rdo0eO7uhk" style="border-bottom: Black 2.5pt double; text-align: right">144,700</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20240930__srt--MajorCustomersAxis__custom--TotalCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zC0b6kI1RLO1" title="Percentage of total revenue">99</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230701__20230930__srt--MajorCustomersAxis__custom--TotalCustomerMember_z3iggPWLZNk4" style="border-bottom: Black 2.5pt double; text-align: right">248,414</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20230930__srt--MajorCustomersAxis__custom--TotalCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zCL6BFkzgdE3" title="Percentage of total revenue">40</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="15" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the nine months ended September 30,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of total revenue</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of total revenue</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%; text-align: justify">Customer A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20240101__20240930__srt--MajorCustomersAxis__custom--CustomerAMember_zUiia7LqjpId" style="width: 11%; text-align: right" title="Revenue">–</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span style="font-size: 10pt"><span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp0_c20240101__20240930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zqJ5doShXFHi" title="Percentage of total revenue">–</span>%</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerAMember_zaSh6rTiDUmj" style="width: 11%; text-align: right" title="Revenue">215,481</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zMXrSul1Kgv1" title="Percentage of total revenue">12</span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20240930__srt--MajorCustomersAxis__custom--CustomerBMember_z3FDCYdTLMW9" style="text-align: right">74,713</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240930__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zC9SW67htyA7" title="Percentage of total revenue">25</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerBMember_zQVvXPHwovgg" style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerBMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zpMjsHLOlDh5" title="Percentage of total revenue">–</span>%</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Customer C</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20240930__srt--MajorCustomersAxis__custom--CustomerCMember_zhI8jOiHPmOb" style="text-align: right">25,901</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240930__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zlDBOsRVMvfd" title="Percentage of total revenue">8</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerCMember_zbWcoYws0cD4" style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerCMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zzkSgELgQEf" title="Percentage of total revenue">–</span>%</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Customer D</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20240930__srt--MajorCustomersAxis__custom--CustomerDMember_zGuRTCjTJcti" style="text-align: right">144,700</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240930__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zUZBfxAQ2jEf" title="Percentage of total revenue">48</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerDMember_z7UqL7UxNSF3" style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerDMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zYqHOn0eDbh8" title="Percentage of total revenue">–</span>%</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Customer E</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20240930__srt--MajorCustomersAxis__custom--CustomerEMember_zTDmezmr23y1" style="border-bottom: Black 1pt solid; text-align: right">19,687</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240930__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zwGMCc8dWbOl" title="Percentage of total revenue">6</span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_d0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerEMember_z48IYPm3UiV2" style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-size: 10pt"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp0_c20230101__20230930__srt--MajorCustomersAxis__custom--CustomerEMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_z18pLe789TT5" title="Percentage of total revenue">–</span>%</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20240101__20240930__srt--MajorCustomersAxis__custom--TotalCustomerMember_z3dBPOoBrHF7" style="border-bottom: Black 2.5pt double; text-align: right">265,001</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240930__srt--MajorCustomersAxis__custom--TotalCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zxOnJY2ZCqWc" title="Percentage of total revenue">87</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20230101__20230930__srt--MajorCustomersAxis__custom--TotalCustomerMember_zmfGIRtQO5F8" style="border-bottom: Black 2.5pt double; text-align: right">215,481</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230930__srt--MajorCustomersAxis__custom--TotalCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_zC06YVMvsNz5" title="Percentage of total revenue">12</span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zyq1CkOHi129" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Details of supplier who accounted for 10% or more of the Company’s total purchase for the three and nine months ended September 30, 2024 and 2023 are as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--SchedulesOfConcentrationOfRiskByRiskFactor1TextBlock_zkTiGFuUgNO4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Supplier concentration)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B3_zIVjf2UKOqk6" style="display: none">Schedule of concentration risk total purchase</span></td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td><td> </td> <td colspan="3" style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="15" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the three months ended September 30,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td></tr> <tr style="vertical-align: bottom"> <td style="width: 40%; text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; width: 2%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; width: 11%; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Amount</b></span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; width: 2%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; width: 11%; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>% of total purchase</b></span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; width: 2%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; width: 11%; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Amount</b></span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; width: 2%; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1pt solid; width: 11%; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>% of total purchase</b></span></td><td style="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Supplier A</td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_d0_c20240701__20240930__srt--MajorCustomersAxis__custom--SupplierAMember_zD2W8GQrNKqj" style="text-align: right" title="Purchases">140,553</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20240701__20240930__srt--MajorCustomersAxis__custom--SupplierAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember_zJq4rp16r1O7" title="Percentage of total purchases">100</span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230701__20230930__srt--MajorCustomersAxis__custom--SupplierAMember_zjPivZM1asS9" style="text-align: right">630,774</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20230701__20230930__srt--MajorCustomersAxis__custom--SupplierAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember_z9LTP8dlw3Ki" title="Percentage of total purchases">98</span>%</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="15" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the nine months ended September 30,</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of total purchase</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">% of total purchase</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 40%; text-align: justify">Supplier A</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20240101__20240930__srt--MajorCustomersAxis__custom--SupplierAMember_z88AkgV3Zrsi" style="width: 11%; text-align: right" title="Purchases">263,145</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20240101__20240930__srt--MajorCustomersAxis__custom--SupplierAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember_zJsUYpEWNet4" title="Percentage of total purchases">100</span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--CostOfGoodsAndServicesSold_pp0p0_c20230101__20230930__srt--MajorCustomersAxis__custom--SupplierAMember_zYE0mqq4qAk1" style="width: 11%; text-align: right">2,255,410</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20230101__20230930__srt--MajorCustomersAxis__custom--SupplierAMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--CostOfGoodsTotalMember_zucF6knnorki" title="Percentage of total purchases">99</span>%</td><td style="width: 1%; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zyuXY3jGq7og" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q3 us-gaap Inventory Net
InventoryNet
1297376 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
1252150 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
0 usd
us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
0 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
144241 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
142635 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
38825 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18067 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
105416 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
124568 usd
CY2024Q3 us-gaap Depreciation
Depreciation
6713 usd
CY2023Q3 us-gaap Depreciation
Depreciation
6781 usd
CY2024Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.25 pure
CY2024Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.25 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25 pure
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-53941 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23031 usd
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25 pure
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25 pure
CY2024Q3 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-13485 usd
CY2023Q3 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
5758 usd
CY2024Q3 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
13485 usd
CY2023Q3 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-5758 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-254896 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-225530 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25 pure
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-63724 usd
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-56383 usd
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
63724 usd
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
56383 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 QSJC Value Added Tax Rate
ValueAddedTaxRate
0.01 pure
CY2024Q3 QSJC Value Added Tax Rate
ValueAddedTaxRate
0.13 pure
QSJC Value Added Tax Rate
ValueAddedTaxRate
0.13 pure
CY2024Q3 QSJC Amounts Due From Related Parties Current
AmountsDueFromRelatedPartiesCurrent
0 usd
CY2023Q4 QSJC Amounts Due From Related Parties Current
AmountsDueFromRelatedPartiesCurrent
1695750 usd
CY2024Q3 QSJC Amounts Due To Related Parties Current
AmountsDueToRelatedPartiesCurrent
2942868 usd
CY2023Q4 QSJC Amounts Due To Related Parties Current
AmountsDueToRelatedPartiesCurrent
4387838 usd
CY2024Q3 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
144700 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
144700 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4381550 shares
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
CY2024Q3 QSJC Reserve Required Annual Rate
ReserveRequiredAnnualRate
0.10 pure
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-008012-index-headers.html Edgar Link pending
0001683168-24-008012-index.html Edgar Link pending
0001683168-24-008012.txt Edgar Link pending
0001683168-24-008012-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qsjc-20240930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
qsjc-20240930_lab.xml Edgar Link unprocessable
qsjc-20240930_cal.xml Edgar Link unprocessable
qsjc-20240930_def.xml Edgar Link unprocessable
qsjc-20240930_pre.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tancheng_ex3101.htm Edgar Link pending
tancheng_ex3102.htm Edgar Link pending
tancheng_ex3201.htm Edgar Link pending
tancheng_ex3202.htm Edgar Link pending
tancheng_i10q-093024.htm Edgar Link pending
tancheng_i10q-093024_htm.xml Edgar Link completed